Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Risk scores

Features identifying low-, moderate-, and high-risk NSTE ACS patients are described using the thrombolysis in myocardial infarction (TIMI) risk score in Table 5-1.13... [Pg.90]

TABLE 5-1. TIMI Risk Score for Non-ST-Segment Elevation Acute Coronary Syndromes2 17... [Pg.91]

Use of aspirin within the past 7 days Using the TIMI Risk Score One point is assigned for each of the seven medical history and... [Pg.91]

TIMI risk score TIMI risk score TIMI risk score... [Pg.91]

Antman EM, Cohen M, Bernink PJ, et al. The TIMI risk score for unstable angina/non-ST-segment elevation MI a method for prognostication and therapeutic decision-making. JAMA 2000 284 835-842. [Pg.105]

It is clear that patients with febrile neutropenia represent a heterogeneous group. Some patients are at lower risk and potentially could be treated as outpatients, thereby avoiding the risk and cost of hospitalization. The Multinational Association for Supportive Care in Cancer (MASCC) has validated a risk-assessment tool that assigns a risk score to patients presenting with febrile neutropenia7 (Table 96-3). Patients with a risk-index score of 21 or greater are identified as low risk and are candidates for outpatient therapy (discussed under Treatment ). [Pg.1469]

Patients with NSTE ACS who are considered to be at low risk (based on TIMI risk score) should have serial biochemical markers obtained. If they are negative, the patient may be admitted to a general medical floor with ECG telemetry monitoring, undergo a noninvasive stress test, or may be discharged. [Pg.60]

The Italian study subanalysis identifies as independent predictors of VTE age > 60 years, height > 165 cm, and diastolic blood pressure > 90 mm. Also relevant is the association between high global cardiovascular risk scores and VTE incidence. This means that there is a correlation between arterial and venous risks, and consequently prevention of arterial complications will also mean lower venous risk (Decensi et al. 2005 Goldhaber 2005) (Fig. 10.9). [Pg.264]

A thorough clinical evaluation with a systematic anamnesis and physical examination including body weight, height, waist/hip ratio, and blood pressure should precede any lab tests or instrumental examinations. In the process of detecting the weak points of a given woman, the application of specific risk scores can be of interest. [Pg.342]

Healthy lifestyle is mandatory for all postmenopausal women together with adequate correction of detected risk factors. That is why this intervention is in the center of the diagram and concerns 100% of the women in this period. Then a decision must be made as to whether the woman s risk profile calls for any intervention beyond lifestyle improvement. The use of surrogate markers or risk scores can be useful in evaluating individual patients. [Pg.352]

Composite billion infrastructure, risk score 1990 million 12% discount rate, percent rate, million risk, million GDP, percent... [Pg.295]

Antman developed a thrombosis in myocardial infarction (TIMI) risk score based on a database of 15,078 patients with STEMI or new onset of complete left bundle branch block (8), The score was validated in the TIMI 9 data set. Ten characteristics of these patients accounted for 97% of the predictive capacity of their multivariate model. These are included in the risk score (Table I). Points were given for difference parameters as listed in Table I. The risk score had a strong association with 30-day mortality. There was a greater >40-fold increase in mortality from TIMI risk score 0 to >8 at 30 days (Table I) (8), The TIMI risk score is easy to apply and can be done at the bedside. [Pg.465]

T ble 1 TIMI risk score for ST-segment elevation myocardial infarction ... [Pg.466]

Morrow DA, Antman EM, Charlesworth A, et al. The TIMI risk score for ST elevation myocardial infarction a convenient bedside clinical score for risk assessment at presentation. Circulation 2000 102 203 I -2037. [Pg.471]

Preventing CIN is of particular importance in patients with diabetes and chronic kidney disease, as these are two of the most powerful independent risk factors for CIN (77), Diabetics are more susceptible to (CIN) than are the nondiabetics, and diabetics with pre-existing chronic kidney disease (CKD) are at even greater risk (78). In a recently proposed CIN risk-scoring system, patient characteristics such as diabetes, age >75, chronic congestive heart failure, admission with acute pulmonary edema, hypotension, anemia and chronic kidney disease and various procedure-related characteristics including increasing volumes of contrast media, and intra-aortic balloon pump use were all found to reliably contribute to increased risk (79). [Pg.478]

Mehran R, Aymong ED, Nikolsky E, et al. A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention development and initial validation. J Am Coll Cardiol 2004 44 1393-1399. [Pg.481]

The prognostic significance of the proposed risk score for CIN extended to prediction of one-year mortality, as indicated by the results obtained from both the development and validation datasets. (Solid bars) development dataset (open bars) validation dataset Abbreviations CIN, contrast-induced nephropathy CKD, chronic kidney disease. Source From Refs. 7, 13. [Pg.495]

The system then adjusts these scores to account for the way different compounds react in the different media — air, ground water, and surface water. On the basis primarily of a compound s half-life in a medium and on dispersion patterns, we assign each compound a separate inherent risk score for each medium. The scale we use is very coarse each level is 10 times greater than the previous level. The data now in the model is, therefore, insensitive to risks that are only two or thre times as great as others. We found it convenient to express the ten-fold differences on a logarithmic unit scale. [Pg.121]

In another blinded study, neurodevelopmental and neurobehavioral performance were prospectively assessed in 131 neonates (mean age 43 hours) exposed in utero to cocaine, with or without other dmgs (279). Cocaine-exposed neonates were developmentally at risk in the tests compared with infants exposed to other drugs alone or in combination. As in the previous study, larger amounts of cocaine were associated with higher neurobehavioral risk scores. [Pg.515]

A prognostic model is the mathematical combination of two or more patient or disease characteristics to predict outcome. Confusingly, prognostic models are also termed prognostic indexes, risk scores, probability models, risk stratification schemes or clinical prediction rules (Reilly and Evans 2006). To be useful, they must be shown to predict clinically relevant outcomes reliably. They must, therefore, be derived from a representative cohort in which outcome has been measured accurately. Next, they must be validated, not just in the data from which they were derived (internal validation) but also on data from independent cohorts (external validation) (Wyatt and Altman 1995 Justice et al. 1999 Altman and Royston 2000). Lastly, a model must be simple to use and have clinical credibility, otherwise it is unlikely to be taken up in routine clinical practice (Table 14.1). [Pg.180]

On the other hand, a potential problem with simple risk scores is that they may not use the full information from the prognostic variables (Christensen 1987 Royston et al. 2006). If continuous predictors such as age are dichotomized (e.g. old versus young), power is usually reduced (Altman and Royston 2000). Furthermore, if the dichotomy is data derived at the point where it looks best, it may also compromise the generalizability of the score. However, although some loss of prognostic power is almost inevitable, simple scores often perform almost as well as more complex models. One reason for this is that a simple score based on a small number of highly predictive variables is much less likely to be overfitted than a complex score with additional weakly predictive variables and interaction terms. [Pg.188]

Identification of high-risk patients simple risk scores... [Pg.196]


See other pages where Risk scores is mentioned: [Pg.21]    [Pg.40]    [Pg.217]    [Pg.345]    [Pg.357]    [Pg.166]    [Pg.73]    [Pg.73]    [Pg.49]    [Pg.328]    [Pg.66]    [Pg.303]    [Pg.51]    [Pg.466]    [Pg.471]    [Pg.496]    [Pg.497]    [Pg.181]    [Pg.182]    [Pg.188]    [Pg.188]    [Pg.197]    [Pg.204]    [Pg.218]   


SEARCH



© 2024 chempedia.info